Emily Keit, Shing Fung Lee, Melissa Woodward, Agata Rembielak, Kevin Shiue, Isacco Desideri, Eva Oldenburger, Maya Bienz, Dirk Rades, Marilena Theodorou, Mervin B Agyeman, Joel Yarney, John Michael Bryant, Hsiang-Hsuan Michael Yu, Charles B Simone, Peter Hoskin, Peter A S Johnstone
BACKGROUND: Improvements in radiation delivery and systemic therapies have resulted in few remaining indications for palliative whole brain radiation therapy (WBRT). Most centers preferentially use stereotactic radiotherapy (SRT) and reserve WBRT for those with >15 lesions, leptomeningeal presentation, rapidly progressive disease, or limited estimated survival. Despite regional differences among preferred dose, fractionation, and treatment technique, we predict survival post-WBRT will remain poor-indicating appropriate application of WBRT in this era of SRT and improved systemic therapies...
September 20, 2023: Annals of Palliative Medicine